Effect of Sensory Integration in Diplegic Cerebral Palsy
1 other identifier
interventional
20
1 country
1
Brief Summary
The purpose of this study is to compare the effects of sensory integration therapy (SIT) applied in addition to neurodevelopmental treatment (NDT) on Motor Function, Balance, and Trunk Control in diplegia cerebral palsy
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2020
CompletedFirst Submitted
Initial submission to the registry
June 11, 2024
CompletedFirst Posted
Study publicly available on registry
June 17, 2024
CompletedJune 17, 2024
June 1, 2024
4 months
June 11, 2024
June 14, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Gross Motor Function Measure-88 (GMFM-88)
The evaluation is organized into sections based on different motor skills: Section A covers lying and rolling, Section B includes sitting, Section C focuses on crawling and kneeling, Section D assesses standing, and Section E includes walking, running, and jumping. Altogether, there are 88 items: Section A (17 items), Section B (20 items), Section C (14 items), Section D (13 items), and Section E (24 items). The minimum clinically important difference (MCID) ranges from 0.8 to 1.6 for a medium effect size and 1.3 to 2.6 for a larger effect size.
8 weeks
Secondary Outcomes (2)
Pediatric Balance Scale (PBS)
8 weeks
Trunk Control Measurement Scale (TCMS)
8 weeks
Study Arms (2)
The experimental group
EXPERIMENTALThe experimental group received sensory integration therapy in addition to the NDT program.Both groups participated in NDT sessions for 45 minutes, three times a week, over a span of 8 weeks.
Control Group
OTHERThe NDT program was customized for each child, incorporating a unique blend of static and dynamic balance exercises, coordination exercises, mobility exercises, and strength training exercises.Both groups participated in NDT sessions for 45 minutes, three times a week, over a span of 8 weeks.
Interventions
The experimental group received sensory integration therapy in addition to the NDT program. The NDT program is customized for each child, featuring a unique blend of static and dynamic balance exercises, coordination exercises, mobility exercises, and strength training exercises. Participants attended 45-minute NDT and sensory integration sessions three times a week for 8 weeks. Sensory integration therapy, visual perception activities (block design, shape recognition in pictures, puzzles, matching geometric shapes and letters, numbers and classification exercises), body awareness activities (showing body parts, drawing life-size drawings, turning left and right, recognizing body parts by touching ), tactile perception exercises (feeling and touching various textures and shapes) and visual-motor coordination training (eye tracking exercises, activities with moving objects and panel activities).
The NDT program is customized for each child, featuring a mix of static and dynamic balance exercises, coordination exercises, mobility exercises, and strength training exercises. He attended 45-minute NDT sessions three times a week for 8 weeks. There is no treatment or medication other than NDT.
Eligibility Criteria
You may qualify if:
- Participants must be between the ages of 4 and 17.
- Participants must be classified as Level II, III, or IV according to the Gross Motor Function Classification System (GMFCS).
You may not qualify if:
- Participants who had previously received sensory integration therapy, - Undergone Botulinum Toxin-A injections, or surgical interventions in the past year.
- Participants who were using pharmacological agents affecting muscle tone.
- Participants with an uncontrolled history of epilepsy.
- Participants who were unable to attend the study regularly.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Halic Universitylead
Study Sites (1)
Ziya Special Education and Rehabilitation Center
Istanbul, Kagıthane, 34408, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ayşen Canan Pakeloğlu, MSc
Halic University
- PRINCIPAL INVESTIGATOR
Seda Saka, Asst. Prof.
Halic University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Information regarding the allocation of each group was not provided and outcome assessment was performed by an investigator blinded to group allocation
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MSc Student
Study Record Dates
First Submitted
June 11, 2024
First Posted
June 17, 2024
Study Start
January 1, 2020
Primary Completion
April 30, 2020
Study Completion
April 30, 2020
Last Updated
June 17, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share